2026 Q1 Portfolio Activity
In 2026 Q1, Sio Capital Management, LLC maintained a portfolio of 92 distinct positions. The most significant new addition was CORCEPT THERAPEUTICS INC, now representing 3.90% of the total fund value. They heavily accumulated shares in CENCORA INC, increasing the position by 534.6%. Conversely, Sio Capital Management, LLC completely exited their position in THE CIGNA GROUP.
Position History
hover any row below to update
Loading…
Total Positions
92
Quarter
2026 Q1
Top Holding
MMS (7.1%)
Top 10 Concentration
45.1%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 92
Sio Capital Management, LLC Full Holdings List — 2026 Q1
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MMS
MAXIMUS INC
|
Industrials | 7.07% | 6.79% |
#1
3
Prev: #4
|
7.8 | 268,521 | 53.7% |
P
S
|
768,825 | $49,281,683 | 2024 Q3 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
WAY
WAYSTAR HLDG CO...
|
Healthcare | 5.68% | 3.16% |
#2
8
Prev: #10
|
6.8 | 1,028,511 | 167.6% |
P
S
|
1,642,236 | $39,594,310 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
ICLR
ICON PLC
|
Healthcare | 4.86% | 3.65% |
#3
6
Prev: #9
|
5.9 | 179,156 | 140.8% |
P
S
|
306,358 | $33,901,576 | 2017 Q3 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
COR
CENCORA INC
|
Healthcare | 4.55% | 0.84% |
#4
28
Prev: #32
|
5.3 | 84,994 | 534.6% |
P
S
|
100,894 | $31,694,841 | 2009 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
DNTH
DIANTHUS THERAP...
|
Healthcare | 4.45% | 3.08% |
#5
7
Prev: #12
|
2.3 | -104,458 | -22.0% |
P
S
|
370,045 | $31,054,176 | 2025 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
AVR
ANTERIS TECHNOL...
|
Healthcare | 4.28% | 1.47% |
#6
15
Prev: #21
|
4.7 | 3,508,324 | 187.1% |
P
S
|
5,382,965 | $29,875,456 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
CORT
CORCEPT THERAPE...
|
Healthcare | 3.90% | — |
#7
Prev: #—
|
5.1 | 674,759 | — |
NEW
|
674,759 | $27,199,535 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
LIVN
LIVANOVA PLC
|
Healthcare | 3.84% | 3.12% |
#8
3
Prev: #11
|
4.0 | 99,233 | 30.8% |
P
S
|
421,615 | $26,797,849 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
TYRA
TYRA BIOSCIENCE...
|
Healthcare | 3.33% | 2.18% |
#9
7
Prev: #16
|
3.3 | 79,437 | 15.1% |
P
S
|
605,439 | $23,188,314 | 2022 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
CELC
CELCUITY INC
|
Healthcare | 3.17% | 7.48% |
#10
9
Prev: #1
|
1.3 | -283,224 | -59.4% |
P
S
|
193,843 | $22,125,240 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
GSK
GSK PLC
|
Healthcare | 3.05% | — |
#11
Prev: #—
|
4.7 | 385,879 | — |
NEW
|
385,879 | $21,296,662 | 2014 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
ANIP
ANI PHARMACEUTI...
|
Healthcare | 2.93% | 1.08% |
#12
13
Prev: #25
|
4.2 | 178,271 | 204.3% |
P
S
|
265,543 | $20,420,257 | 2021 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
ABT
ABBOTT LABORATO...
|
Healthcare | 2.75% | — |
#13
Prev: #—
|
4.6 | 186,574 | — |
NEW
|
186,574 | $19,155,553 | 2015 Q2 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
EMBC
EMBECTA CORP
|
Healthcare | 2.34% | — |
#14
Prev: #—
|
4.4 | 1,847,850 | — |
NEW
|
1,847,850 | $16,334,994 | 2023 Q3 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
ABVX
ABIVAX SA
|
Healthcare | 2.17% | 0.91% |
#15
14
Prev: #29
|
3.9 | 92,676 | 214.9% |
P
S
|
135,800 | $15,121,330 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
VIR
VIR BIOTECHNOLO...
|
Healthcare | 1.93% | 0.45% |
#16
27
Prev: #43
|
3.8 | 1,020,277 | 213.3% |
P
S
|
1,498,620 | $13,427,635 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
HAE
HAEMONETICS COR...
|
Healthcare | 1.78% | 1.17% |
#17
7
Prev: #24
|
3.7 | 128,041 | 138.2% |
P
S
|
220,672 | $12,437,074 | 2025 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
SION
SIONNA THERAPEU...
|
Healthcare | 1.69% | — |
#18
Prev: #—
|
4.2 | 294,340 | — |
NEW
|
294,340 | $11,800,091 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
SNY
SANOFI SA
|
Healthcare | 1.66% | 7.41% |
#19
16
Prev: #3
|
0.7 | -732,015 | -75.3% |
P
S
|
239,671 | $11,547,349 | 2014 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
RAPP
RAPPORT THERAPE...
|
Healthcare | 1.65% | 0.88% |
#20
11
Prev: #31
|
3.7 | 181,544 | 98.0% |
P
S
|
366,809 | $11,477,454 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
TFX
TELEFLEX INCORP...
|
Healthcare | 1.63% | 1.67% |
#21
1
Prev: #20
|
2.7 | 7,924 | 9.1% |
P
S
|
94,800 | $11,339,028 | 2023 Q3 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
BMRN
BIOMARIN PHARMA...
|
Healthcare | 1.57% | 2.18% |
#22
7
Prev: #15
|
1.1 | -38,462 | -16.5% |
P
S
|
194,226 | $10,971,827 | 2020 Q3 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
CCRN
CROSS CTRY HEAL...
|
Healthcare | 1.48% | 1.36% |
#23
Prev: #23
|
1.1 | 29,572 | 2.8% |
P
S
|
1,098,393 | $10,324,894 | 2019 Q2 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
TARA
PROTARA THERAPE...
|
Healthcare | 1.47% | 1.44% |
#24
2
Prev: #22
|
2.6 | 254,445 | 14.8% |
P
S
|
1,969,839 | $10,262,861 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
GPCR
STRUCTURE THERA...
|
Healthcare | 1.45% | 2.20% |
#25
11
Prev: #14
|
1.1 | 7,593 | 3.8% |
P
S
|
209,093 | $10,078,283 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
BHVN
BIOHAVEN LTD
|
Healthcare | 1.41% | 2.21% |
#26
13
Prev: #13
|
1.1 | -80,838 | -6.5% |
P
S
|
1,163,926 | $9,846,814 | 2022 Q2 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
MNPR
MONOPAR THERAPE...
|
Healthcare | 1.36% | — |
#27
Prev: #—
|
4.0 | 173,506 | — |
NEW
|
173,506 | $9,506,394 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
EYPT
EYEPOINT INC
|
Healthcare | 1.33% | — |
#28
Prev: #—
|
4.0 | 721,785 | — |
NEW
|
721,785 | $9,303,809 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
CRNX
CRINETICS PHARM...
|
Healthcare | 1.30% | 0.91% |
#29
1
Prev: #30
|
3.5 | 125,046 | 100.2% |
P
S
|
249,887 | $9,075,896 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
EWTX
EDGEWISE THERAP...
|
Healthcare | 1.22% | 0.93% |
#30
2
Prev: #28
|
2.5 | 31,505 | 13.3% |
P
S
|
268,986 | $8,473,059 | 2025 Q2 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
CMPS
COMPASS PATHWAY...
|
Healthcare | 1.19% | — |
#31
Prev: #—
|
4.0 | 1,506,525 | — |
NEW
|
1,506,525 | $8,331,083 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
OCUL
OCULAR THERAPEU...
|
Healthcare | 1.18% | — |
#32
Prev: #—
|
4.0 | 968,597 | — |
NEW
|
968,597 | $8,204,017 | 2019 Q2 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
AQST
AQUESTIVE THERA...
|
Healthcare | 1.14% | 1.01% |
#33
7
Prev: #26
|
3.5 | 929,792 | 93.6% |
P
S
|
1,922,887 | $7,979,981 | 2025 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
RLMD
RELMADA THERAPE...
|
Healthcare | 0.96% | — |
#34
Prev: #—
|
3.9 | 965,000 | — |
NEW
|
965,000 | $6,716,400 | 2022 Q3 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
ORKA
ORUKA THERAPEUT...
|
Healthcare | 0.93% | 0.56% |
#35
3
Prev: #38
|
2.4 | 14,370 | 12.2% |
P
S
|
132,496 | $6,498,929 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
ZBIO
ZENAS BIOPHARMA...
|
Healthcare | 0.93% | — |
#36
Prev: #—
|
3.9 | 331,730 | — |
NEW
|
331,730 | $6,485,322 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
DRUG
BRIGHT MINDS BI...
|
Healthcare | 0.90% | 1.01% |
#37
10
Prev: #27
|
2.4 | 4,200 | 5.1% |
P
S
|
86,083 | $6,281,477 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
QDEL
QUIDELORTHO COR...
|
Healthcare | 0.85% | — |
#38
Prev: #—
|
3.8 | 359,011 | — |
NEW
|
359,011 | $5,898,551 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
ZBH
ZIMMER BIOMET H...
|
Healthcare | 0.81% | 5.45% |
#39
34
Prev: #5
|
0.3 | -323,029 | -83.8% |
P
S
|
62,613 | $5,661,467 | 2009 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
REPL
REPLIMUNE GROUP...
|
Healthcare | 0.79% | — |
#40
Prev: #—
|
3.8 | 720,036 | — |
NEW
|
720,036 | $5,508,275 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
OGN
ORGANON & CO
|
Healthcare | 0.74% | 3.86% |
#41
33
Prev: #8
|
0.3 | -2,555,857 | -74.7% |
P
S
|
865,908 | $5,186,789 | 2021 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
OKUR
ONKURE THERAPEU...
|
Healthcare | 0.64% | — |
#42
Prev: #—
|
3.8 | 1,078,965 | — |
NEW
|
1,078,965 | $4,466,915 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
IRON
DISC MEDICINE I...
|
Healthcare | 0.60% | 0.72% |
#43
9
Prev: #34
|
2.2 | 7,617 | 13.2% |
P
S
|
65,203 | $4,169,080 | 2024 Q2 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
PMVP
PMV PHARMACEUTI...
|
Healthcare | 0.55% | 0.52% |
#44
4
Prev: #40
|
2.2 | 440,032 | 16.7% |
P
S
|
3,076,580 | $3,814,959 | 2020 Q3 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
IMNM
IMMUNOME INC
|
Healthcare | 0.52% | — |
#45
Prev: #—
|
3.7 | 165,110 | — |
NEW
|
165,110 | $3,610,956 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
IART
INTEGRA LIFESCI...
|
Healthcare | 0.52% | — |
#46
Prev: #—
|
3.7 | 383,140 | — |
NEW
|
383,140 | $3,609,179 | 2024 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
SVRA
SAVARA INC
|
Healthcare | 0.48% | 0.58% |
#47
10
Prev: #37
|
1.2 | no change | no change |
P
S
|
613,888 | $3,351,828 | 2019 Q2 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
CNC
PUT
CENTENE CORP DE...
|
PUT Option | 0.47% | — |
#48
Prev: #—
|
3.7 | 100,000 | — |
NEW
|
100,000 | $3,274,000 | 2021 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
PRQR
PROQR THERAPEUT...
|
Healthcare | 0.45% | 0.69% |
#49
14
Prev: #35
|
0.7 | -209,466 | -9.7% |
P
S
|
1,954,715 | $3,166,638 | 2021 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
SI
SHOULDER INNOVA...
|
Unknown | 0.44% | 0.51% |
#50
9
Prev: #41
|
0.7 | -17,330 | -7.6% |
P
S
|
210,641 | $3,060,614 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-14 |
Showing 1-50 of 92 holdings